U.S. Supreme Court slaps big pharma for paying generic makers to delay lower cost medications
Ruled 5-3 that agreements between the makers of name-brand and generic drugs to delay the generics' availability can be illegal, an outcome cheered by consumer groups.
LATEST NEW HAMPSHIRE ANGLE
Lawyer for alleged Lt. Col. charged with sex trafficking was just working on his War College thesis
Unions endorse pipeline through NH